Knowledge base
1,506 claims across 14 domains
Every claim is an atomic argument with evidence, traceable to a source. Browse by domain or search semantically.
All 1,506ai alignment 363internet finance 293health 281space development 211entertainment 165grand strategy 121energy 23mechanisms 18collective intelligence 14robotics 5manufacturing 5critical systems 3unknown 3teleological economics 1
EU AI Act high-risk enforcement deadline became legally active April 28, 2026 when the Omnibus trilogue failed, creating the first mandatory AI governance enforcement date in history without a legislative escape clause
The second political trilogue on the Digital Omnibus for AI collapsed on April 28, 2026 after 12 hours of negotiations. The structural failure centered on conformity-assessment architecture for Annex I products (AI embedded in medical devices, machinery, diagnostics, vehicles). Parliament wanted sec
EU AI Act military exclusion gap means the most consequential frontier AI deployments remain outside mandatory governance scope even if civilian enforcement occurs
The EU AI Act explicitly excludes military AI systems from its scope. This creates a fundamental governance gap: even if August 2, 2026 enforcement happens for civilian high-risk systems, the most consequential AI deployments—Pentagon systems, classified military applications, autonomous weapons—are
Governance instrument instrumentalization represents a distinct failure mode where safety-adjacent regulatory authority retains formal validity while its function inverts from public safety enforcement to commercial negotiation leverage
The Pentagon's Anthropic designation reveals a governance failure mode distinct from the existing Mode 1-5 taxonomy: **governance instrument instrumentalization**—where safety-adjacent regulations are deliberately used as commercial negotiation tools rather than for stated public safety purposes.
Internal employee governance fails to constrain frontier AI military deployment because 580+ employees including senior technical researchers could not prevent a classified AI deployment they characterized as harmful
The Google-Pentagon deal reveals a critical failure mode in employee governance as an alignment mechanism. On April 27, 2026, 580+ Google employees—including 20+ directors/VPs and senior DeepMind researchers—sent a letter to CEO Sundar Pichai urging rejection of the classified Pentagon AI deal. The
Pentagon's Anthropic supply chain designation fails four independent legal tests (statutory scope, procedural adequacy, pretext, logical coherence) revealing its function as commercial negotiation leverage rather than genuine security enforcement
Lawfare's systematic legal analysis identifies four independent structural flaws in the Pentagon's supply chain risk designation of Anthropic under 10 U.S.C. § 3252:
AI video generation crossed from experimental to planned episodic production workflow at major streamer scale in 2026
House of David Season 2 (Amazon Prime, March 2026) integrated 253 AI-generated shots compared to 73 in Season 1 — a 3.5x increase in one production cycle. Critically, Season 2 had 'AI planned as workflow from start, not as a backup solution,' marking the transition from experimental to operational d
AI video production workflow creates editorial abundance through 20x generation ratio rather than traditional single-asset VFX crafting
House of David's production workflow generates '20 times' the number of AI shots compared to final VFX shots used in the show. 'Batches of AI content are given to editorial to sift through like traditional footage. Only shots that make the cut get upscaled to final quality.' This represents a fundam
August 2026 dual enforcement geometry creates bifurcated AI compliance environment through opposite military-civilian requirements
Two independent enforcement timelines converge in August 2026 creating the first governance moment where AI labs face simultaneous deadlines requiring opposite compliance postures. The Hegseth mandate (January 2026, 180-day deadline ~July 9) requires all DoD AI contracts to accept 'any lawful use' t
Pentagon exclusion creates EU civilian compliance advantage through pre-aligned safety practices when enforcement proceeds
Anthropic's Pentagon exclusion (April 2026, Mythos/supply-chain risk designation) is typically analyzed as pure market access loss: removal from ~$100B+ in US military AI contracts. The regulatory geometry reframes this as a dual effect with a potential regulatory asset component. The categorical pr
Three-level form governance architecture creates mutually reinforcing accountability absorption through executive mandate, corporate nominal compliance, and legislative information requests
The three-level architecture operates through structural interdependence, not additive failure. Level 1 (Hegseth mandate): Secretary Hegseth's AI strategy memo mandated 'any lawful use' language in ALL DoD AI contracts within 180 days, converting the MAD mechanism into legal compliance requirement a
Adolescents face compounded GLP-1 eating disorder risk because ED prevalence peaks during adolescence while social media exposure is highest
The review identifies adolescents as the highest-risk population for GLP-1-induced eating disorder harm through a developmental timing mechanism. Two factors converge: (1) eating disorder prevalence peaks during adolescence, creating a large vulnerable population, and (2) adolescent social media use
No RCT evidence exists for GLP-1 receptor agonists in anorexia nervosa despite pharmacovigilance signals showing 4-7x elevated eating disorder risk
This review explicitly confirms that evidence for GLP-1 receptor agonists in anorexia nervosa (AN) is 'extremely limited' with theoretical risks rather than empirical data. The paper states that risks for restrictive eating disorders include 'appetite suppression masking restrictive behaviors, compu
GLP-1 eating disorder pharmacovigilance signal (aROR 4.17-6.80) is a class effect that emerged specifically in the obesity treatment population after June 2021, not in the prior metabolic population
Analysis of 2,061,901 adverse event reports through December 2024 found eating disorder signals with adjusted Reporting Odds Ratios between 4.17 and 6.80 across dulaglutide, semaglutide, and liraglutide—the highest magnitude psychiatric signal in the study. Critically, sensitivity analysis revealed
GLP-1 eating disorder risk is subtype-specific: protective for binge eating disorder but potentially harmful for restrictive eating disorders through the same appetite suppression mechanism
This review establishes that GLP-1 receptor agonists create opposing clinical outcomes across eating disorder subtypes through a single pharmacological mechanism. For binge eating disorder (BED), GLP-1 RAs reduce binge episodes by modulating mesolimbic dopamine circuits that drive reward-based eatin
GLP-1 eating disorder screening gap is structural capacity failure not clinical knowledge deficit because professional society guidance requires tri-specialist care teams unavailable in primary care settings where most prescriptions originate
NEDA and ANAD jointly recommend that GLP-1 prescribing for patients with eating disorder risk factors require a tri-specialist care team: a physician versed in both GLP-1s and eating disorders, a therapist experienced with both GLP-1s and ED treatment, and a dietitian familiar with this medication c
GLP-1 GI side effects trigger purging behaviors in vulnerable populations creating direct pharmacological harm pathway not just psychological reinforcement
ANAD documents that GLP-1 receptor agonists' most common side effects—nausea, vomiting, diarrhea, and gastroparesis—'can trigger or worsen purging behaviors' in individuals with eating disorder histories or vulnerabilities. This is not an indirect psychological effect but a direct pharmacological pa
Pre-treatment eating disorder screening is recommended by clinical reviews but not required by any professional guideline or regulatory body despite 4-7x elevated pharmacovigilance risk
This review provides detailed clinical recommendations for eating disorder risk mitigation: (1) pre-treatment screening using SCOFF questionnaire for eating disorder history, compensatory behaviors, body image, and emotion regulation; (2) ongoing monitoring of eating behaviors, mood, and suicidal id
GLP-1 social media promotion for cosmetic weight loss creates a novel eating disorder onset pathway in vulnerable populations through unscreened access
The review identifies social media as a mechanism through which GLP-1 misuse reaches eating-disorder-vulnerable populations. Social media promotes GLP-1s 'for esthetic purposes' as miracle weight-loss treatments, which could trigger restrictive eating behaviors in vulnerable individuals. This create
WHO December 2025 GLP-1 obesity guideline contains no eating disorder screening requirement despite pharmacovigilance signal predating guideline by 18+ months
The WHO issued a global guideline on December 1, 2025, recommending GLP-1 receptor agonists (semaglutide and two other agents) for long-term obesity treatment in adults. The guideline news release identifies only one explicit population exclusion: pregnant women. No eating disorder contraindications
CFTC Rule 40.11(a)(1) creates a preemption paradox because the CFTC's own prohibition on DCM gaming contracts undermines its claim to exclusive jurisdiction over gaming-adjacent products
Judge Roth's dissent identified a critical logical flaw in the CFTC's field preemption argument: CFTC Rule 40.11(a)(1) PROHIBITS designated contract markets from listing gaming contracts. If the CFTC itself excludes gaming contracts from DCM trading, this undermines the claim that CFTC has exclusive
Massachusetts SJC oral argument signals state courts will allow state gambling law to coexist with CFTC regulation of DCM event contracts
The Massachusetts Supreme Judicial Court's oral argument on May 4, 2026 revealed strong judicial skepticism toward Kalshi's federal preemption defense. Justice Scott Kafker directly told Kalshi's lawyer 'I just feel like you're swimming upstream here' when arguing for CFTC preemption of state licens
Ninth Circuit oral argument signals pro-state ruling on prediction market preemption creating circuit split with Third Circuit
During the April 16, 2026 Ninth Circuit oral argument in consolidated Nevada cases (Kalshi, Robinhood, Crypto.com vs. Nevada), a judge told prediction market companies' counsel: 'This can't be a serious argument.' This unusually dismissive language from an appellate judge signals the court has littl
Ninth Circuit and SJC simultaneous skepticism of CFTC preemption means state authority over prediction markets is becoming the majority judicial view
The Massachusetts SJC oral argument on May 4, 2026 occurred less than three weeks after the Ninth Circuit oral argument on April 16, 2026, which also signaled pro-state leanings. The compound signal is significant: two independent courts in different jurisdictions (state supreme court and federal ap
Third Circuit's expansive swap definition classifies sports event contracts as financial derivatives by interpreting commercial consequence to include any stakeholder financial impact
The Third Circuit interpreted CEA Section 1a(47)(A)'s swap definition to cover 'any agreement, contract, or transaction that provides for any payment or delivery that is dependent on the occurrence, nonoccurrence, or the extent of the occurrence of an event or contingency associated with a potential
A 1 million satellite orbital data center constellation at 500-2000km altitude represents the most extreme test of orbital debris governance yet proposed by adding collision risk that exceeds the entire current tracked debris population by 40x
SpaceX's January 2026 FCC filing for up to 1 million satellites in the 500-2000km altitude range represents a qualitative shift in orbital debris risk, not just a quantitative increase. The current orbital environment contains approximately 6,000 operational satellites and 24,000 tracked debris obje
Page 4 of 61